MARKET

ATAI

ATAI

Atai Beckley Inc
NASDAQ
4.400
+0.340
+8.37%
After Hours: 4.430 +0.03 +0.67% 19:59 12/04 EST
OPEN
4.070
PREV CLOSE
4.060
HIGH
4.540
LOW
4.060
VOLUME
5.57M
TURNOVER
--
52 WEEK HIGH
6.75
52 WEEK LOW
1.150
MARKET CAP
1.60B
P/E (TTM)
-5.4081
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ATAI last week (1124-1128)?
Weekly Report · 3d ago
Weekly Report: what happened at ATAI last week (1117-1121)?
Weekly Report · 11/24 10:27
AtaiBeckley: Strong Buy Rating Backed by Promising Clinical Data and Robust Financial Position
TipRanks · 11/19 19:35
Weekly Report: what happened at ATAI last week (1110-1114)?
Weekly Report · 11/17 10:27
Psychedelic: Atai Beckley, Cybin report quarterly earnings
TipRanks · 11/13 16:31
ATAI Life Sciences’ BPL-003 Gains Momentum with Breakthrough Therapy Designation and Strategic Merger, Reinforcing Buy Rating
TipRanks · 11/13 16:15
ATAI Life Sciences: Promising Clinical Developments and Strong Financial Position Drive Buy Rating
TipRanks · 11/13 14:06
AtaiBeckley Advances Mental Health Therapies with FDA Milestone
TipRanks · 11/13 04:34
More
About ATAI
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.

Webull offers Atai Beckley NV stock information, including NASDAQ: ATAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATAI stock methods without spending real money on the virtual paper trading platform.